Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TechnologyAdvice

- PMLiVE

Janssen/Pharmacyclics’ ibrutinib shows continued survival benefit in chronic lymphocytic leukaemia

The slow-growing blood cancer affects approximately 4.92 per 100,000 people every year in Europe

- PMLiVE

Pfizer shares positive overall survival results for Elrexfio in multiple myeloma

The blood cancer is responsible for more than 187,000 new cases worldwide every year

- PMLiVE

Celltrion’s RoActemra biosimilar shows promise in phase 3 rheumatoid arthritis study

The chronic inflammatory disease affects approximately 1% of the population worldwide

- PMLiVE

Maximising the impact of creativity in healthcare

Embracing challenge and disruption to energise creative campaigns

- PMLiVE

AbbVie gains rights to FutureGen’s inflammatory bowel disease candidate in deal worth $1.7bn

The agreement gives AbbVie exclusive global rights to the TL1A-targeting monoclonal antibody

- PMLiVE

Bristol Myers Squibb’s Augtyro granted expanded FDA approval for solid tumours

The drug was approved by the US regulator last year to treat ROS1-positive NSCLC

- PMLiVE

Roche’s spinal muscular atrophy treatment Evrysdi shows continued benefit in children

The progressive neuromuscular disease affects approximately one in every 10,000 babies

- PMLiVE

Pfizer/Flagship’s drug discovery partnership to focus on obesity treatments

The agreement with Profound Therapeutics is the first to be initiated under the partnership

Can Cinderella save us?

KCL research could speed up discovery of new antibiotics in fight against AMR

According to WHO, AMR is designated as one of the top ten global public health threats facing humanity

- PMLiVE

Innovation in oncology

Iona Everson from PMGroup spoke to Jack Harris, Vice President of Oncology at GSK, about his career path and his drive to improve patient care

- PMLiVE

Men’s Health Week: The Power of Conversation

We're launching a number of schemes to help support men's mental health throughout the year. This Men's Health Week, make sure you check out some of our plans.

Mednet

Maximizing KOL Engagement with Asynchronous Tools

Dive into the variety of asynchronous tools available on the Impetus InSite Platform® with our ninth tip. Learn how different tools can enhance your virtual touchpoints and elevate the quality...

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links